Brief: 20 People In Japan Who Took Amgen's Tavneos Have Died, And At Least 22 Developed A Potentially Fatal Liver Injury, As Per Kissei Pharmaceutical- WSJ
May 15 (Reuters) - Kissei Pharmaceutical Co Ltd 4547.T: 20 PEOPLE IN JAPAN WHO TOOK AMGEN’S TAVNEOS HAVE DIED, AND AT LEAST 22 DEVELOPED A POTENTIALLY FATAL LIVER INJURY, AS PER KISSEI PHARMACEUTICAL- WSJ KISSEI TOLD DOCTORS FRIDAY TO STOP PRESCRIBING AMGEN'S TAVNEOS DRUG TO NEW PATIENTS - WSJ Source text: https://tinyurl.com/mrk4hevp Further company coverage: 4547.T ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Amgen
See all newsFactbox: Global drugmakers invest billions to boost US presence
China's Harbour BioMed to focus on another patent case after $20 million damages award
Amgen owes $20.2 million in antibody patent lawsuit, US jury says (updated)
Amgen owes $20.2 mln in antibody patent lawsuit, US jury says
Amgen taps research firm to reassess Tavneos data (updated)